Tomei L. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. IJPAI [Internet]. 2023 Jan. 12 [cited 2024 Apr. 26];36(4):40-1. Available from: https://www.riaponline.it/article/view/106